0 XP   0   0   0

Medmen Enterprises Inc Class B
Buy, Hold or Sell?

I guess you are interested in Medmen Enterprises Inc Class B. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Medmen

Let's start. I'm going to help you getting a better view of Medmen Enterprises Inc Class B. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Medmen Enterprises Inc Class B even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Medmen Enterprises Inc Class B is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Medmen Enterprises Inc Class B. The closing price on 2022-10-03 was $0.038 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Medmen Enterprises Inc Class B Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Medmen Enterprises Inc Class B.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Medmen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Medmen to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -273.4% means that $[indicator name=netProfitMargin&period=MRQ&percentage=1 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Medmen Enterprises Inc Class B:

  • The MRQ is -273.4%. The company is making a huge loss. -2
  • The TTM is -181.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-273.4%TTM-181.3%-92.1%
TTM-181.3%YOY-67.2%-114.1%
TTM-181.3%5Y-173.9%-7.5%
5Y-173.9%10Y-173.9%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-273.4%-0.9%-272.5%
TTM-181.3%0.3%-181.6%
YOY-67.2%0.1%-67.3%
5Y-173.9%-0.9%-173.0%
10Y-173.9%-0.3%-173.6%
1.1.2. Return on Assets

Shows how efficient Medmen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medmen to the Drug Manufacturers-Specialty & Generic industry mean.
  • -28.2% Return on Assets means that Medmen generated $-0.28 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Medmen Enterprises Inc Class B:

  • The MRQ is -28.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.2%TTM-15.8%-12.3%
TTM-15.8%YOY-5.1%-10.7%
TTM-15.8%5Y-9.1%-6.7%
5Y-9.1%10Y-9.1%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.2%0.1%-28.3%
TTM-15.8%0.1%-15.9%
YOY-5.1%-0.1%-5.0%
5Y-9.1%-0.2%-8.9%
10Y-9.1%-0.1%-9.0%
1.1.3. Return on Equity

Shows how efficient Medmen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medmen to the Drug Manufacturers-Specialty & Generic industry mean.
  • -60.0% Return on Equity means Medmen generated $-0.60 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Medmen Enterprises Inc Class B:

  • The MRQ is -60.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -33.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-60.0%TTM-33.5%-26.5%
TTM-33.5%YOY-9.5%-24.1%
TTM-33.5%5Y-23.3%-10.2%
5Y-23.3%10Y-23.3%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-60.0%0.6%-60.6%
TTM-33.5%0.4%-33.9%
YOY-9.5%0.4%-9.9%
5Y-23.3%-0.3%-23.0%
10Y-23.3%0.1%-23.4%

1.2. Operating Efficiency of Medmen Enterprises Inc Class B.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medmen is operating .

  • Measures how much profit Medmen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medmen to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -29.7% means the company generated $-0.30  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Medmen Enterprises Inc Class B:

  • The MRQ is -29.7%. The company is operating very inefficient. -2
  • The TTM is -49.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-29.7%TTM-49.2%+19.5%
TTM-49.2%YOY-28.1%-21.1%
TTM-49.2%5Y-142.7%+93.5%
5Y-142.7%10Y-142.7%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.7%2.5%-32.2%
TTM-49.2%1.6%-50.8%
YOY-28.1%2.7%-30.8%
5Y-142.7%2.0%-144.7%
10Y-142.7%1.3%-144.0%
1.2.2. Operating Ratio

Measures how efficient Medmen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 1.78 means that the operating costs are $1.78 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Medmen Enterprises Inc Class B:

  • The MRQ is 1.784. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.682. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.784TTM1.682+0.103
TTM1.682YOY1.944-0.263
TTM1.6825Y2.985-1.303
5Y2.98510Y2.9850.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7841.497+0.287
TTM1.6821.446+0.236
YOY1.9441.389+0.555
5Y2.9851.370+1.615
10Y2.9851.182+1.803

1.3. Liquidity of Medmen Enterprises Inc Class B.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medmen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 0.49 means the company has $0.49 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Medmen Enterprises Inc Class B:

  • The MRQ is 0.495. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.461. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.495TTM0.461+0.034
TTM0.461YOY0.410+0.051
TTM0.4615Y0.705-0.244
5Y0.70510Y0.7050.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4951.902-1.407
TTM0.4611.908-1.447
YOY0.4102.112-1.702
5Y0.7052.173-1.468
10Y0.7051.891-1.186
1.3.2. Quick Ratio

Measures if Medmen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medmen to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.02 means the company can pay off $0.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Medmen Enterprises Inc Class B:

  • The MRQ is 0.020. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.126. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.020TTM0.126-0.106
TTM0.126YOY0.091+0.035
TTM0.1265Y0.131-0.005
5Y0.13110Y0.1310.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0200.667-0.647
TTM0.1260.792-0.666
YOY0.0910.819-0.728
5Y0.1310.838-0.707
10Y0.1310.823-0.692

1.4. Solvency of Medmen Enterprises Inc Class B.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medmen assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 1.99 means that Medmen assets are financed with 198.5% credit (debt) and the remaining percentage (100% - 198.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Medmen Enterprises Inc Class B:

  • The MRQ is 1.985. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.596. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.985TTM1.596+0.390
TTM1.596YOY1.428+0.167
TTM1.5965Y0.961+0.634
5Y0.96110Y0.9610.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9850.433+1.552
TTM1.5960.425+1.171
YOY1.4280.396+1.032
5Y0.9610.402+0.559
10Y0.9610.404+0.557
1.4.2. Debt to Equity Ratio

Measures if Medmen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 422.7% means that company has $4.23 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Medmen Enterprises Inc Class B:

  • The MRQ is 4.227. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.370. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.227TTM3.370+0.857
TTM3.370YOY2.865+0.505
TTM3.3705Y2.252+1.118
5Y2.25210Y2.2520.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2270.668+3.559
TTM3.3700.677+2.693
YOY2.8650.624+2.241
5Y2.2520.686+1.566
10Y2.2520.705+1.547

2. Market Valuation of Medmen Enterprises Inc Class B

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Medmen.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -0.22 means the investor is paying $-0.22 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Medmen Enterprises Inc Class B:

  • The EOD is -0.142. Company is losing money. -2
  • The MRQ is -0.217. Company is losing money. -2
  • The TTM is -0.677. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.142MRQ-0.217+0.075
MRQ-0.217TTM-0.677+0.460
TTM-0.677YOY-0.566-0.111
TTM-0.6775Y-1.805+1.128
5Y-1.80510Y-1.8050.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-0.142-0.010-0.132
MRQ-0.217-0.067-0.150
TTM-0.677-0.006-0.671
YOY-0.566-0.031-0.535
5Y-1.8053.518-5.323
10Y-1.8054.263-6.068
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Medmen.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Medmen Enterprises Inc Class B:

  • The MRQ is -0.006. Very Bad. -2
  • The TTM is 0.009. Very good. +2
Trends
Current periodCompared to+/- 
MRQ-0.006TTM0.009-0.014
TTM0.009YOY-0.021+0.029
TTM0.0095Y-0.012+0.020
5Y-0.01210Y-0.0120.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0060.003-0.009
TTM0.0090.019-0.010
YOY-0.0210.024-0.045
5Y-0.0120.023-0.035
10Y-0.0120.026-0.038

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Medmen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of -0.22 means the investor is paying $-0.22 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Medmen Enterprises Inc Class B:

  • The EOD is -0.144. Bad. Book ratio is negative. -2
  • The MRQ is -0.220. Bad. Book ratio is negative. -2
  • The TTM is -0.728. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-0.144MRQ-0.220+0.076
MRQ-0.220TTM-0.728+0.508
TTM-0.728YOY-0.593-0.135
TTM-0.7285Y-0.181-0.547
5Y-0.18110Y-0.1810.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1441.407-1.551
MRQ-0.2201.588-1.808
TTM-0.7282.019-2.747
YOY-0.5932.258-2.851
5Y-0.1811.986-2.167
10Y-0.1811.531-1.712

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Medmen Enterprises Inc Class B compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share---0.263-0.232-12%-0.379+44%-0.111-58%-0.111-58%
Book Value Per Share Growth---0.0590.021-376%0.022-368%-0.024-59%-0.024-59%
Current Ratio--0.4950.461+7%0.410+21%0.705-30%0.705-30%
Debt To Asset Ratio--1.9851.596+24%1.428+39%0.961+107%0.961+107%
Debt To Equity Ratio--4.2273.370+25%2.865+48%2.252+88%2.252+88%
Dividend Per Share----0%-0%-0%-0%
Eps---0.075-0.067-11%-0.048-36%-0.102+36%-0.102+36%
Eps Growth--38.073-36.225+195%-9.725+126%-6.412+117%-6.412+117%
Gains Per Share---0.0590.021-376%0.022-368%-0.024-59%-0.024-59%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---2.734-1.813-34%-0.672-75%-1.739-36%-1.739-36%
Operating Margin---0.297-0.492+66%-0.281-5%-1.427+381%-1.427+381%
Operating Ratio--1.7841.682+6%1.944-8%2.985-40%2.985-40%
Pb Ratio-0.144+34%-0.220-0.728+230%-0.593+169%-0.181-18%-0.181-18%
Pe Ratio-0.142+34%-0.217-0.677+213%-0.566+161%-1.805+733%-1.805+733%
Peg Ratio---0.0060.009-165%-0.021+261%-0.012+107%-0.012+107%
Price Per Share0.038-53%0.0580.166-65%0.218-73%0.982-94%0.982-94%
Quick Ratio--0.0200.126-84%0.091-78%0.131-85%0.131-85%
Return On Assets---0.282-0.158-44%-0.051-82%-0.091-68%-0.091-68%
Return On Equity---0.600-0.335-44%-0.095-84%-0.233-61%-0.233-61%
 EOD+1 -2MRQTTM+5 -13YOY+5 -135Y+6 -1210Y+6 -12

3.2. Fundamental Score

Let's check the fundamental score of Medmen Enterprises Inc Class B based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.142
Price to Book Ratio (EOD)Between0-1-0.144
Net Profit Margin (MRQ)Greater than0-2.734
Operating Margin (MRQ)Greater than0-0.297
Quick Ratio (MRQ)Greater than10.020
Current Ratio (MRQ)Greater than10.495
Debt to Asset Ratio (MRQ)Less than11.985
Debt to Equity Ratio (MRQ)Less than14.227
Return on Equity (MRQ)Greater than0.15-0.600
Return on Assets (MRQ)Greater than0.05-0.282
Total0/10 (0.0%)

3.3. Technical Score

Let's check the technical score of Medmen Enterprises Inc Class B based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.167
Ma 20Greater thanMa 500.048
Ma 50Greater thanMa 1000.054
Ma 100Greater thanMa 2000.063
OpenGreater thanClose0.035
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Other Operating Expenses  5388,3388,876-9127,964-5,5662,398-4,075-1,677



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets323,224
Total Liabilities641,736
Total Stockholder Equity151,808
 As reported
Total Liabilities 641,736
Total Stockholder Equity+ 151,808
Total Assets = 323,224

Assets

Total Assets323,224
Total Current Assets161,496
Long-term Assets161,496
Total Current Assets
Cash And Cash Equivalents 10,796
Short-term Investments 2,738
Net Receivables 3,810
Inventory 10,011
Other Current Assets 127,752
Total Current Assets  (as reported)161,496
Total Current Assets  (calculated)155,107
+/- 6,389
Long-term Assets
Property Plant Equipment 111,757
Goodwill 9,810
Intangible Assets 35,746
Other Assets 4,414
Long-term Assets  (as reported)161,727
Long-term Assets  (calculated)161,727
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities326,417
Long-term Liabilities315,319
Total Stockholder Equity151,808
Total Current Liabilities
Short Long Term Debt 97,004
Accounts payable 20,497
Other Current Liabilities 168,067
Total Current Liabilities  (as reported)326,417
Total Current Liabilities  (calculated)285,567
+/- 40,850
Long-term Liabilities
Long term Debt 206,379
Capital Lease Obligations Min Short Term Debt92,457
Other Liabilities 38,296
Long-term Liabilities  (as reported)315,319
Long-term Liabilities  (calculated)337,131
+/- 21,812
Total Stockholder Equity
Total Stockholder Equity (as reported)151,808
Total Stockholder Equity (calculated)0
+/- 151,808
Other
Common Stock Shares Outstanding 1,209,449
Net Debt 292,586
Net Invested Capital 455,191
Net Tangible Assets 106,252
Net Working Capital -164,921



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
> Total Assets 
0
91,465
178,606
282,190
374,365
466,453
552,070
634,630
849,407
844,012
811,401
574,264
534,176
534,176
487,331
472,464
531,893
490,872
431,980
323,224
323,224431,980490,872531,893472,464487,331534,176534,176574,264811,401844,012849,407634,630552,070466,453374,365282,190178,60691,4650
   > Total Current Assets 
0
29,616
51,987
111,429
111,585
144,048
104,874
115,783
139,330
151,164
123,916
84,044
87,989
87,989
117,415
96,679
165,506
134,815
170,963
161,496
161,496170,963134,815165,50696,679117,41587,98987,98984,044123,916151,164139,330115,783104,874144,048111,585111,42951,98729,6160
       Cash And Cash Equivalents 
0
1,652
12,213
79,160
63,499
78,219
21,897
33,754
42,236
26,000
31,802
10,094
10,310
10,320
21,314
11,873
78,223
47,724
14,411
10,796
10,79614,41147,72478,22311,87321,31410,32010,31010,09431,80226,00042,23633,75421,89778,21963,49979,16012,2131,6520
       Short-term Investments 
0
0
0
0
6,500
9,499
19,516
13,019
16,045
12,367
4,014
3,787
3,037
3,037
3,037
3,037
0
0
0
2,738
2,7380003,0373,0373,0373,0373,7874,01412,36716,04513,01919,5169,4996,5000000
       Net Receivables 
0
9,584
23,966
3,827
6,366
9,871
1,224
1,487
3,152
13,300
14,074
9,328
22,921
7,192
6,659
2,366
6,790
9,369
9,398
3,810
3,8109,3989,3696,7902,3666,6597,19222,9219,32814,07413,3003,1521,4871,2249,8716,3663,82723,9669,5840
       Other Current Assets 
0
3,092
3,207
8,954
10,105
12,686
6,216
3,248
2,927
56,235
47,369
33,534
30,427
49,183
72,394
52,546
61,093
56,987
135,220
127,752
127,752135,22056,98761,09352,54672,39449,18330,42733,53447,36956,2352,9273,2486,21612,68610,1058,9543,2073,0920
   > Long-term Assets 
0
0
0
0
0
0
447,196
518,847
710,076
692,848
687,484
490,220
446,187
446,187
369,916
375,785
366,386
356,057
261,017
161,727
161,727261,017356,057366,386375,785369,916446,187446,187490,220687,484692,848710,076518,847447,196000000
       Property Plant Equipment 
0
23,294
64,940
88,748
122,596
131,005
195,411
220,989
399,494
436,880
437,913
290,903
256,960
156,198
134,177
215,253
135,028
134,563
91,738
111,757
111,75791,738134,563135,028215,253134,177156,198256,960290,903437,913436,880399,494220,989195,411131,005122,59688,74864,94023,2940
       Goodwill 
0
6,164
8,515
18,165
18,165
84,818
108,232
85,561
91,934
61,322
61,322
33,861
33,861
33,861
32,900
32,900
32,900
32,900
32,939
9,810
9,81032,93932,90032,90032,90032,90033,86133,86133,86161,32261,32291,93485,561108,23284,81818,16518,1658,5156,1640
       Intangible Assets 
0
27,478
45,401
48,793
110,792
96,339
130,663
175,553
179,209
166,827
162,457
148,081
138,438
138,438
115,334
115,380
111,406
107,578
71,922
35,746
35,74671,922107,578111,406115,380115,334138,438138,438148,081162,457166,827179,209175,553130,66396,339110,79248,79345,40127,4780
       Other Assets 
0
4,913
7,764
15,055
11,227
10,243
12,890
36,744
39,440
27,819
25,793
17,375
16,928
17,138
12,631
12,252
12,136
11,662
10,854
4,414
4,41410,85411,66212,13612,25212,63117,13816,92817,37525,79327,81939,44036,74412,89010,24311,22715,0557,7644,9130
> Total Liabilities 
0
40,875
103,456
84,993
128,755
174,751
292,664
433,781
671,005
726,257
738,740
751,152
726,513
726,513
709,711
726,097
732,933
710,201
679,122
641,736
641,736679,122710,201732,933726,097709,711726,513726,513751,152738,740726,257671,005433,781292,664174,751128,75584,993103,45640,8750
   > Total Current Liabilities 
0
32,731
86,241
81,400
128,755
87,743
84,382
114,934
129,916
188,831
184,506
189,215
198,095
198,095
282,684
288,608
345,240
326,024
375,108
326,417
326,417375,108326,024345,240288,608282,684198,095198,095189,215184,506188,831129,916114,93484,38287,743128,75581,40086,24132,7310
       Short-term Debt 
19,271
11,192
49,788
52,354
60,149
33,487
11,244
20,230
13,147
20,269
0
0
0
17,067
97,170
0
145,963
135,563
107,739
0
0107,739135,563145,963097,17017,06700020,26913,14720,23011,24433,48760,14952,35449,78811,19219,271
       Short Long Term Debt 
19,271
11,192
49,788
52,354
60,149
33,487
11,244
20,230
13,147
20,269
16,942
16,189
17,067
16,761
97,170
103,496
110,632
114,339
96,867
97,004
97,00496,867114,339110,632103,49697,17016,76117,06716,18916,94220,26913,14720,23011,24433,48760,14952,35449,78811,19219,271
       Accounts payable 
0
14,075
10,258
3,613
9,148
26,204
36,881
49,794
53,849
82,920
65,551
78,964
53,331
138,484
111,360
35,064
139,871
132,890
113,257
20,497
20,497113,257132,890139,87135,064111,360138,48453,33178,96465,55182,92053,84949,79436,88126,2049,1483,61310,25814,0750
       Other Current Liabilities 
0
816
23,443
12,935
36,071
27,744
11,002
10,170
9,497
60,756
86,507
73,609
93,896
42,543
74,154
117,846
59,406
57,571
154,112
168,067
168,067154,11257,57159,406117,84674,15442,54393,89673,60986,50760,7569,49710,17011,00227,74436,07112,93523,4438160
   > Long-term Liabilities 
0
0
0
0
0
0
208,282
318,847
541,089
537,426
554,233
561,937
528,418
528,418
427,027
437,490
387,694
384,177
304,014
315,319
315,319304,014384,177387,694437,490427,027528,418528,418561,937554,233537,426541,089318,847208,282000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
162,975
92,846
0
85,573
85,533
74,398
0
074,39885,53385,573092,846162,9750000000000000
       Other Liabilities 
0
0
0
0
0
17,548
23,465
55,456
74,335
31,461
36,382
53,227
51,153
48,842
51,896
50,027
61,183
54,166
18,796
38,296
38,29618,79654,16661,18350,02751,89648,84251,15353,22736,38231,46174,33555,45623,46517,54800000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
46,996
48,105
0
57,676
50,800
15,572
0
015,57250,80057,676048,10546,9960000000000000
> Total Stockholder Equity
33,580
50,589
75,150
109,590
179,523
270,304
291,872
236,055
264,460
258,310
255,374
159,889
167,254
-192,337
213,118
191,760
251,129
234,197
205,573
151,808
151,808205,573234,197251,129191,760213,118-192,337167,254159,889255,374258,310264,460236,055291,872270,304179,523109,59075,15050,58933,580
   Common Stock
0
29,075
107,447
129,146
206,775
288,043
365,011
556,651
629,762
666,195
700,322
83
83
0
-222,400
-253,600
0
0
0
0
0000-253,600-222,40008383700,322666,195629,762556,651365,011288,043206,775129,146107,44729,0750
   Retained Earnings Total Equity0-820,968-791,208-772,1880-679,596-649,1500000000000000
   Accumulated Other Comprehensive Income 00000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
816,321
892,714
0
1,023,317
1,025,405
1,026,541
0
01,026,5411,025,4051,023,3170892,714816,3210000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
21,514
-32,296
0
0
0
0
0
0
0
0
0
0
83
0
0
0
0
0
0
000000830000000000-32,29621,5140



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2022-06-30)

Gross Profit (+$)
totalRevenue140,812
Cost of Revenue-71,084
Gross Profit69,72769,727
 
Operating Income (+$)
Gross Profit69,727
Operating Expense-202,114
Operating Income-61,302-132,386
 
Operating Expense (+$)
Research Development-
Selling General Administrative111,930
Selling And Marketing Expenses-
Operating Expense202,114111,930
 
Net Interest Income (+$)
Interest Income92
Interest Expense-43,073
Net Interest Income-42,981-42,981
 
Pretax Income (+$)
Operating Income-61,302
Net Interest Income-42,981
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-175,4519,866
EBIT - interestExpense = -104,375
-205,083
-152,114
Interest Expense43,073
Earnings Before Interest and Taxes (ebit)-61,302-132,378
Earnings Before Interest and Taxes (ebitda)-106,731
 
After tax Income (+$)
Income Before Tax-175,451
Tax Provision--9,896
Net Income From Continuing Ops-165,555-165,555
Net Income-195,187
Net Income Applicable To Common Shares-195,187
 
Non-recurring Events
Discontinued Operations-45,339
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-4,959
Total Other Income/Expenses Net-71,16842,981
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
XTGLOBAL.BSE
1 minute ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XTGLOBAL.BSE.

XTGLOBAL.BSE Daily Candlestick Chart
XO.BK
18 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XO.BK.

XO.BK Daily Candlestick Chart
SE-ED.BK
18 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SE-ED.BK.

SE-ED.BK Daily Candlestick Chart
UPA.BK
18 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of UPA.BK.

UPA.BK Daily Candlestick Chart
STA.BK
20 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STA.BK.

STA.BK Daily Candlestick Chart
PRECHA.BK
20 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PRECHA.BK.

PRECHA.BK Daily Candlestick Chart
ERW.BK
23 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ERW.BK.

ERW.BK Daily Candlestick Chart
EFORL.BK
23 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EFORL.BK.

EFORL.BK Daily Candlestick Chart
ECL.BK
23 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ECL.BK.

ECL.BK Daily Candlestick Chart
CHOW.BK
23 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CHOW.BK.

CHOW.BK Daily Candlestick Chart
BIZ.BK
23 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BIZ.BK.

BIZ.BK Daily Candlestick Chart
AIE.BK
24 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AIE.BK.

AIE.BK Daily Candlestick Chart
SUNILTX.BSE
42 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of SUNILTX.BSE.

SUNILTX.BSE Daily Candlestick Chart
BONLON.BSE
44 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of BONLON.BSE.

BONLON.BSE Daily Candlestick Chart
ZYDUSLIFE.BSE
48 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZYDUSLIFE.BSE.

ZYDUSLIFE.BSE Daily Candlestick Chart
WHIRLPOOL.BSE
48 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WHIRLPOOL.BSE.

WHIRLPOOL.BSE Daily Candlestick Chart
ULTRACEMCO.BSE
50 minutes ago

I found you a Golden Cross on the daily chart of ULTRACEMCO.BSE.

ULTRACEMCO.BSE Daily Candlestick Chart
UMAEXPORTS.BSE
50 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of UMAEXPORTS.BSE.

UMAEXPORTS.BSE Daily Candlestick Chart
TRITURBINE.BSE
51 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TRITURBINE.BSE.

TRITURBINE.BSE Daily Candlestick Chart
TRIVENIENT.BSE
51 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIVENIENT.BSE.

TRIVENIENT.BSE Daily Candlestick Chart
TIDEWATER.BSE
52 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TIDEWATER.BSE.

TIDEWATER.BSE Daily Candlestick Chart
LAND.JK
52 minutes ago

I found you a Death Cross on the daily chart of LAND.JK.

LAND.JK Daily Candlestick Chart
INRU.JK
52 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of INRU.JK.

INRU.JK Daily Candlestick Chart
PANKAJPO.BSE
52 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PANKAJPO.BSE.

PANKAJPO.BSE Daily Candlestick Chart
VICO.JK
53 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VICO.JK.

VICO.JK Daily Candlestick Chart